Denca designs control system for pharma facility

Published: 3-Mar-2011
Manufacturing Finance Pharmaceutical

Project in Liverpool worth £500,000

UK-based automation and control systems specialist Denca Controls has been commissioned by a UK producer of pharmaceuticals and biotechnology to supply control systems for its new manufacturing facility in Liverpool in a project worth £500,000.

The new plant is being built to meet demand for the pharmaceutical firm’s dialysis substitute, which frees patients from the need to be connected to a dialysis machine for 8 hours at a time, instead enabling blood to be cleaned from the convenience of a portable bag.

Denca, based in Widnes, Cheshire has used its expertise to develop process diagrams, design and manufacture control panels, as well as provide software, programming, installation and commissioning. In total, five Siemens S7300 PLCs will be networked with MP 277 touchscreen HMIs, a Profibus Remote IO and communication.

John Talbot, sales and marketing director at Denca, said: ‘It’s not often in our line of work that you are given the opportunity to help, in however small a way, to improve lives. In this case, it’s hugely rewarding to know that, through the implementation of control systems for this groundbreaking new product, we would ultimately be helping the company to provide patients with a better control system to make their day to day lives a little easier.’

Denca works across a spectrum of industry sectors including automotive, chemical, food and beverage, healthcare and utilities. It provides process control solutions based on custom-designed, fully integrated PLC and HMI software for both mechanical and electrical operations as well as UKAS-traceable calibration and certification services.

See more

You may also like

Manufacturing

Denca is under control at SAFC plant in Scotland

Read more
Will supply full control system for IPB2 facility at Irvine

Trending Articles

  1. Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Automated visual inspection: reducing false rejects with intelligent bubble masking This article explores how intelligent bubble masking in automated visual inspection systems can significantly reduce false rejects in biopharmaceutical manufacturing by accurately distinguishing harmless bubbles from harmful particles
  3. Axol Bioscience expands ophthalmology portfolio with acquisition of Newcells Biotech business Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, strengthening its iPSC-derived retinal organoid and RPE model offerings
  4. CARBOGEN AMCIS and Celonic unveil integrated ADC development platform at World ADC London 2026 The strategic alliance combines biologics and highly potent payload capabilities to streamline ADC development and manufacturing
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Axplora invests in Le Mans lyophilisation expansion and appoints new site head Axplora has revealed plans to expand lyophilisation capacity at its Le Mans ADC manufacturing site, with CEO Martin Meeson speaking exclusively to Manufacturing Chemist about tightening European capacity and how the investment aims to prevent manufacturing becoming a bottleneck for programmes

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Denca is under control at SAFC plant in Scotland

Will supply full control system for IPB2 facility at Irvine
Manufacturing

Viatris to cut 10% of its global workforce after Indian plant fire

Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
Manufacturing

GEA opens new technology centre in Germany

The opening of the new technology centre for pharmaceutical freeze-drying systems will strengthen the supplier's position in the growing pharmaceutical applications market
Finance

Heligan Group report: UK healthcare M&A remains resilient

A new report from the investment group has highlighted the healthcare field as being a "defensive, structurally supported sector"
Manufacturing

Avoiding product degradation with a low-temperature, vacuum cake dryer

High-performance chemicals often lose efficacy when exposed to heat. Active pharmaceutical ingredients (APIs), fine chemical intermediates, and biologically derived materials are subject to product degradation and can transform, or lose potency under high drying temperatures. This thermal sensitivity demands precise control to maintain molecular stability and ensure product quality
Manufacturing

Cutting-edge customer projects - Specialised systems for multiple sectors

As specialists in laboratory and process chemistry equipment solutions, Labtex have expertise in designing, manufacturing, and installing customised systems for a diverse range industries and disciplines – including chemical manufacturing, drug development, and metals recovery
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Procurement as a strategic business enabler

How Alkermes unlocked $30m in project cost savings with JAGGAER
Subscribe now